Tezacaftor/Ivacaftor in Children ≥6 Years of Age With F508del and Residual Function Changes in CFTR.
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2022 Feb 18;S1569-1993(22)00033-9. doi: 10.1016/j.jcf.2022.02.003.
Document
Link
Theme
Clinical Trials [4]
Pulmonology [5]
Keywords
Ivacaftor [6]
Tezacaftor [7]
Date
Friday, February 18, 2022
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [8]